Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449837 · ClinicalTrials.gov registry record
Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
A clinical trial of Circulating Tumor Cells, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 162
- Enrollment target
- 1
- Study location
NCT02449837: Completed study of Circulating Tumor Cells, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT02449837 is a study of Circulating Tumor Cells that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 162 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02449837, a study of Circulating Tumor Cells, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the level of Circulating Tumor Cells (CTCs) in cancer patients before and after undergoing treatment regimens where the primary treatment modality is radiation therapy (XRT). Specifically, there is interest in the change in CTCs pre- and post- XRT, both in absolute and relative terms.
Conditions Studied
Interventions
- OTHER Blood draw
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill, Department of Radiation Oncology - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2014-05 |
| Est. Completion | 2022-02-20 |
What the finished NCT02449837 record still lists
NCT02449837 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Circulating Tumor Cells appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT02449837 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02449837 about?
NCT02449837 is a clinical study titled "Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy". The purpose of this study is to investigate the level of Circulating Tumor Cells (CTCs) in cancer patients before and after undergoing treatment regimens where the primary treatment modality is radiation therapy (XRT). Specifically, there is interest in the change in CTCs pre- and post- XRT, both in...
What is the current status of trial NCT02449837?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2014-05. Estimated completion is 2022-02-20.
What conditions does trial NCT02449837 study?
This clinical trial studies the following conditions: Circulating Tumor Cells.
What interventions are being tested in trial NCT02449837?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT02449837?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02449837 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Circulating Tumor Cells
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia